Pages that link to "Q28740839"
Jump to navigation
Jump to search
The following pages link to Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis (Q28740839):
Displaying 16 items.
- Current perspectives on systems immunology approaches to rheumatic diseases (Q27687400) (← links)
- Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis (Q28540781) (← links)
- Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (Q34219132) (← links)
- Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future (Q35078327) (← links)
- Increasing consistency of disease biomarker prediction across datasets (Q35150852) (← links)
- No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients (Q35604215) (← links)
- Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance (Q36298955) (← links)
- Microwave and magnetic (M(2) ) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis (Q36989973) (← links)
- Role of toll-like receptors in multiple sclerosis (Q37021687) (← links)
- Multiple sclerosis: individualized disease susceptibility and therapy response. (Q38079620) (← links)
- Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12. (Q47698731) (← links)
- Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood. (Q51025796) (← links)
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? (Q55387906) (← links)
- Elastic net-based prediction of IFN-β treatment response of patients with multiple sclerosis using time series microarray gene expression profiles (Q61796751) (← links)
- A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics (Q61810307) (← links)
- Pharmacogenomics of Multiple Sclerosis: A Systematic Review (Q64100676) (← links)